• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Capital Rx Secures $50 Million to Redefine Prescription Pricing

by Jasmine Pennic 02/02/2021 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
PBM Capital Rx Secures $50 Million to Redefine Prescription Pricing

What You Should Know:

– Capital Rx, the fastest-growing pharmacy benefit manager in the U.S., announced today that it has raised $50 million in Series B financing.

– Following the recent launch of JUDITM, the industry’s first Enterprise Pharmacy Platform, Capital Rx will continue to expand the platform’s capabilities, including leveraging AI to improve clinical care.


Capital Rx, a New York City-based pharmacy benefit manager in the U.S., announced it has raised $50 million in Series B funding led by Transformational Capital, with participation from Edison Partners, who led Capital Rx’s Series A financing in 2019.

 Drug Pricing is Broken: 50x Efficiency Over Existing PBM Systems

Founded in 2017, Capital Rx’s enterprise pharmacy platform, JUDI™, digitally links providers, patients, pharmacies, and plans to achieve the highest standard of clinical care. Using its Clearinghouse ModelTM, inspired by the stock exchange, Capital Rx redefines prescriptions pricing and administration in the U.S. By removing “spread” pricing and other antiquated practices, Capital Rx unlocks value from the pharmacy supply chain, fosters fair competition, and reduces prescription costs for employers while also improving patient outcomes.

Recent Traction/Milestones

Capital Rx has achieved exponential customer growth, with success driven by the management team’s deep domain expertise in software development, clinical management, and supply chain administration. Since its inception, Capital Rx has grown to service hundreds of thousands of members and process millions of prescriptions annually, while maintaining an industry-leading net promoter score (NPS) of 92.

Following the recent launch of JUDI™, the industry’s first Enterprise Pharmacy Platform and fully-integrated patient mobile app, Capital Rx will continue to expand the platform’s capabilities, including leveraging AI to improve clinical care. “The JUDI™ platform represents a significant leap forward in pharmacy benefit management,” said Jared Kesselheim, Managing Partner at Transformation Capital. “The scalability, efficiency, and flexibility of JUDI™ allows employer groups, as well as health plans, to deliver the highest level of care at the lowest price point.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: AI, Capital Rx, Partners, Pharmacy, pharmacy benefit management, prescription benefits

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Virta Health CEO: GLP-1s Didn’t Kill Weight Watchers, Its Broken Model Did

Most-Read

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |